Cephalosporin drugs represent broad-spectrum beta-lactam antibiotics combating Gram-positive and Gram-negative bacterial infections across generations with varying resistance profiles. The global cephalosporin drugs market size was valued at USD 21.61 billion in 2024 and is projected to reach from USD 22.93 billion in 2025 to USD 36.83 billion by 2033, growing at a CAGR of 6.1% during...